HCV-related mortality among male prison inmates in Texas, 1994-2003

Amy J. Harzke, Jacques Baillargeon, Michael F. Kelley, Pamela M. Diamond, Karen J. Goodman, David P. Paar

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Purpose: The prevalence of hepatitis C virus (HCV) infection is high among adult incarcerated populations, but HCV-related mortality data are lacking. The study purpose was to assess HCV-related mortality over time and across racial/ethnic categories from 1994 through 2003 among male prisoners in the Texas Department of Criminal Justice (TDCJ). Methods: TDCJ decedent data were linked with Texas Vital Statistics multiple-cause-of-death data. Crude annual HCV death rates, age- and race-adjusted summary rates, and average annual percent changes were estimated. The proportion of deaths due to chronic liver disease/cirrhosis, liver cancer, hepatitis B, and HIV for which HCV was identified as an intervening or contributing cause of death was calculated. Results: Among Texas male prisoners, HCV death rates were high and increased over the 10-year study period by an average 21% annually, with the largest increase occurring among Hispanic prisoners. HCV was identified as an intervening or contributing cause of death in 15% of chronic liver disease/cirrhosis deaths, 33% of liver cancer deaths, 81% of hepatitis B deaths, and 7% of HIV deaths. Conclusions: Because HCV-related deaths among Texas male prisoners are high and increasing, particularly among Hispanics, targeted prevention, screening, and treatment of HCV infections should be among the priorities of U.S. correctional healthcare systems.

Original languageEnglish (US)
Pages (from-to)582-589
Number of pages8
JournalAnnals of Epidemiology
Volume19
Issue number8
DOIs
StatePublished - Aug 2009

Fingerprint

Prisons
Hepacivirus
Mortality
Prisoners
Cause of Death
Criminal Law
Virus Diseases
Liver Neoplasms
Hepatitis B
Hispanic Americans
Liver Cirrhosis
Liver Diseases
Chronic Disease
HIV
Vital Statistics
Delivery of Health Care

Keywords

  • Hepatitis
  • Liver Diseases
  • Mortality
  • Prisoners
  • Prisons

ASJC Scopus subject areas

  • Epidemiology

Cite this

Harzke, A. J., Baillargeon, J., Kelley, M. F., Diamond, P. M., Goodman, K. J., & Paar, D. P. (2009). HCV-related mortality among male prison inmates in Texas, 1994-2003. Annals of Epidemiology, 19(8), 582-589. https://doi.org/10.1016/j.annepidem.2009.03.009

HCV-related mortality among male prison inmates in Texas, 1994-2003. / Harzke, Amy J.; Baillargeon, Jacques; Kelley, Michael F.; Diamond, Pamela M.; Goodman, Karen J.; Paar, David P.

In: Annals of Epidemiology, Vol. 19, No. 8, 08.2009, p. 582-589.

Research output: Contribution to journalArticle

Harzke, Amy J. ; Baillargeon, Jacques ; Kelley, Michael F. ; Diamond, Pamela M. ; Goodman, Karen J. ; Paar, David P. / HCV-related mortality among male prison inmates in Texas, 1994-2003. In: Annals of Epidemiology. 2009 ; Vol. 19, No. 8. pp. 582-589.
@article{3ac9ee9fc6514dbea9b93505bd981a3c,
title = "HCV-related mortality among male prison inmates in Texas, 1994-2003",
abstract = "Purpose: The prevalence of hepatitis C virus (HCV) infection is high among adult incarcerated populations, but HCV-related mortality data are lacking. The study purpose was to assess HCV-related mortality over time and across racial/ethnic categories from 1994 through 2003 among male prisoners in the Texas Department of Criminal Justice (TDCJ). Methods: TDCJ decedent data were linked with Texas Vital Statistics multiple-cause-of-death data. Crude annual HCV death rates, age- and race-adjusted summary rates, and average annual percent changes were estimated. The proportion of deaths due to chronic liver disease/cirrhosis, liver cancer, hepatitis B, and HIV for which HCV was identified as an intervening or contributing cause of death was calculated. Results: Among Texas male prisoners, HCV death rates were high and increased over the 10-year study period by an average 21{\%} annually, with the largest increase occurring among Hispanic prisoners. HCV was identified as an intervening or contributing cause of death in 15{\%} of chronic liver disease/cirrhosis deaths, 33{\%} of liver cancer deaths, 81{\%} of hepatitis B deaths, and 7{\%} of HIV deaths. Conclusions: Because HCV-related deaths among Texas male prisoners are high and increasing, particularly among Hispanics, targeted prevention, screening, and treatment of HCV infections should be among the priorities of U.S. correctional healthcare systems.",
keywords = "Hepatitis, Liver Diseases, Mortality, Prisoners, Prisons",
author = "Harzke, {Amy J.} and Jacques Baillargeon and Kelley, {Michael F.} and Diamond, {Pamela M.} and Goodman, {Karen J.} and Paar, {David P.}",
year = "2009",
month = "8",
doi = "10.1016/j.annepidem.2009.03.009",
language = "English (US)",
volume = "19",
pages = "582--589",
journal = "Annals of Epidemiology",
issn = "1047-2797",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - HCV-related mortality among male prison inmates in Texas, 1994-2003

AU - Harzke, Amy J.

AU - Baillargeon, Jacques

AU - Kelley, Michael F.

AU - Diamond, Pamela M.

AU - Goodman, Karen J.

AU - Paar, David P.

PY - 2009/8

Y1 - 2009/8

N2 - Purpose: The prevalence of hepatitis C virus (HCV) infection is high among adult incarcerated populations, but HCV-related mortality data are lacking. The study purpose was to assess HCV-related mortality over time and across racial/ethnic categories from 1994 through 2003 among male prisoners in the Texas Department of Criminal Justice (TDCJ). Methods: TDCJ decedent data were linked with Texas Vital Statistics multiple-cause-of-death data. Crude annual HCV death rates, age- and race-adjusted summary rates, and average annual percent changes were estimated. The proportion of deaths due to chronic liver disease/cirrhosis, liver cancer, hepatitis B, and HIV for which HCV was identified as an intervening or contributing cause of death was calculated. Results: Among Texas male prisoners, HCV death rates were high and increased over the 10-year study period by an average 21% annually, with the largest increase occurring among Hispanic prisoners. HCV was identified as an intervening or contributing cause of death in 15% of chronic liver disease/cirrhosis deaths, 33% of liver cancer deaths, 81% of hepatitis B deaths, and 7% of HIV deaths. Conclusions: Because HCV-related deaths among Texas male prisoners are high and increasing, particularly among Hispanics, targeted prevention, screening, and treatment of HCV infections should be among the priorities of U.S. correctional healthcare systems.

AB - Purpose: The prevalence of hepatitis C virus (HCV) infection is high among adult incarcerated populations, but HCV-related mortality data are lacking. The study purpose was to assess HCV-related mortality over time and across racial/ethnic categories from 1994 through 2003 among male prisoners in the Texas Department of Criminal Justice (TDCJ). Methods: TDCJ decedent data were linked with Texas Vital Statistics multiple-cause-of-death data. Crude annual HCV death rates, age- and race-adjusted summary rates, and average annual percent changes were estimated. The proportion of deaths due to chronic liver disease/cirrhosis, liver cancer, hepatitis B, and HIV for which HCV was identified as an intervening or contributing cause of death was calculated. Results: Among Texas male prisoners, HCV death rates were high and increased over the 10-year study period by an average 21% annually, with the largest increase occurring among Hispanic prisoners. HCV was identified as an intervening or contributing cause of death in 15% of chronic liver disease/cirrhosis deaths, 33% of liver cancer deaths, 81% of hepatitis B deaths, and 7% of HIV deaths. Conclusions: Because HCV-related deaths among Texas male prisoners are high and increasing, particularly among Hispanics, targeted prevention, screening, and treatment of HCV infections should be among the priorities of U.S. correctional healthcare systems.

KW - Hepatitis

KW - Liver Diseases

KW - Mortality

KW - Prisoners

KW - Prisons

UR - http://www.scopus.com/inward/record.url?scp=67649370760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649370760&partnerID=8YFLogxK

U2 - 10.1016/j.annepidem.2009.03.009

DO - 10.1016/j.annepidem.2009.03.009

M3 - Article

VL - 19

SP - 582

EP - 589

JO - Annals of Epidemiology

JF - Annals of Epidemiology

SN - 1047-2797

IS - 8

ER -